Gonadotropin-releasing hormone antagonist linzagolix: possible treatment for assisted reproduction patients presenting with adenomyosis and endometriosis?
This paper explores the potential of gonadotropin-releasing hormone antagonist linzagolix as a treatment option for patients undergoing assisted reproduction who also present with adenomyosis and endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (5)
- Adenomyosis does not affect implantation, but is associated with miscarriage in patients undergoing oocyte donation via openalex
- Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis via openalex
- Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis via openalex
- Single-cell RNA sequencing of oocytes from ovarian endometriosis patients reveals a differential transcriptomic profile associated with lower quality via openalex
- Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis via openalex
Cited by (12)
- Role of oral gonadotropin-releasing hormone antagonists in the management of uterine adenomyosis: a narrative review 2026
- Compromised concept: Link between endometriosis, pregnancy complications and infertility 2025
- The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis 2023
- Medical treatment of adenomyosis: a literature review 2023
- Changes in adenomyosis following elagolix vs leuprolide treatment in a patient with pelvic pain and infertility: A case report 2023
- Gynecological uses of GnRH antagonists: review article 2022
- Nonsurgical management of adenomyosis: an overview of current evidence 2022
- Conservative surgical and drug therapies for adenomyosis Medicine 2022
- Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration 2021
- Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review 2021
- Adenomyosis: Impact on Fertility and Obstetric Outcomes 2021
- Medical Treatment for Endometriosis: Tolerability, Quality of Life and Adherence 2021
Source provenance
- europepmc
- last seen: 2026-10-07T06:10:45.703000+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:21:47.975235+00:00
- unpaywall
- last seen: 2026-09-17T06:32:46.214484+00:00